NMS Company
Oncology Seminars
Oncology Seminars
Nerviano Medical Sciences organizes the Oncology Seminars series, where speakers are regularly invited to present their latest findings. Usually, the topics are focused towards the better understanding of tumorigenic processes and the possible application of current research and technology to discover and develop innovative anti-cancer drugs. Please, see below the upcoming events.
For attendance please contact 0331-5814 67/78.
ARCHIVE:
Archive 2006
- December, 12 2006 (2:00 PM)
Francesco Senigaglia
Bioxell, Segrate, Italy - December, 5 2006 (2:00 PM)
Giorgio Inghirami
CeRMS, University of Turin - November, 28 2006 (2:00 PM)
Multi diversity generation reactions as tools for exploring molecular diversity
Luca Banfi
Dip. Chmica e Chimica Industriale, Università di Genova
Genova - Italy - October, 31 2006 (2:00 PM)
Modified Carbohydrates as tools in Medicinal Chemistry
Francesco Nicotra
Università di Milano Bicocca
Milan - Italy - October, 10 2006 (2:00 PM)
Pathogenesis of hereditary disorders defective in nucleotide-excision repair: from clinical features to molecular defects
Miria Stefanini
Istituto di Genetica Molecolare CNR Pavia - September, 26 2006 (2:00 PM)
Functional interplay between chromatin structure and DNA damage processing in the control of genome stability
Paolo Plevani
Università degli Studi di Milano
Milano - Italy - July, 4 2006 (2:00 PM)
Molecular imaging and nuclear medicine: a research program in oncology
Guido Biasco, Cristina Nanni, Maria Pantaleo
University of Bologna
Bologna - Italy - June, 27 2006 (2:00 PM)
Use of PNAs in the study and for possible therapy of Lymphomas
Manlio Ferrarini
Istituto Nazionale per la Ricerca sul Cancro, IST
Genova - Italy - June, 13 2006 (2:00 PM)
Positron Emission Tomography (PET) as Biomarker in Drug Development
Piero Salvadori
CNR Institute of Clinical Physiology
Pisa - Italy - May, 23 2006 (2:00 PM)
The challenge of Biomarkers for Novel Mechanism-Based Anticancer Therapies
Caroline Dive
University of Manchester and Christie Hospital NHS Trust Withington
Manchester - U.K. - May, 16 2006 (2:00 PM)
Changing Paradigms in Drug Discovery
Hugo Kubinyi
Weisenheim am Sand
Germany - May, 9 2006 (2:00 PM)
Molecular mechanisms of melanoma development and progression
Anja Bosserhoff
Universität Regensburg
Germany - May, 2 2006 (2:00 PM)
Mitotic Checkpoint Kinases in Chromosome Instability and Cancer
Geert Kops
UMC Utrecht
The Netherlands - March, 21 2006 (2:00 PM)
Loco-regional treatments: state of art and future perspective
Luigi Solbiati
General Hospital
Busto Arsizio (Varese) - Italy - March, 7 2006 (2:00 PM)
New approaches for a selective treatment of cancer based on the antibody-directed enzyme prodrug therapy
Lutz Tietze
University of Goettingen
Goettingen - Germany - February, 28 2006 (3:00 PM)
Defects in mismatch repair, processing of DNA damage and genetic instability
Margherita Bignami
Istituto Superiore di Sanità
Roma - February, 21 2006 (2:30 PM)
Molecular basis of Philadelphia-negative chronic myeloproliferative disorders
Mario Cazzola
University of Pavia Medical School
Pavia - Italy - February, 14 2006 (2:00 PM)
Planning and Conduct of Phase I Trials in Oncology
Luca Gianni
Istituto Nazionale per la Cura e lo Studio dei Tumori
Milano - Italy - January, 17 2006 (2:00 PM)
Finding targets of transcription factors in vivo by "ChIP on chip" analysis
Roberto Mantovani
University of Milano
Milano - Italy
Archive 2007
- December, 18 2007 (2-3 PM)
Giovanni Gaudino
University of Piemonte orientale “A.Avogadro”
Novara - December, 4 2007 (2 PM)
Oncology Exploration - panning for gold in biomolecular space
David Lloyd
School of Biochemistry and Immunology Trinity College
Trinity College Dublin, Dublin 2, Ireland
Email: lloyddg@tcd.ie - November, 23 2007 (2,30-3,30 PM)
The mitochondrial regulation of cell death and its possible therapeutic implications
Sten Orrenius
Institute of Environmental Medicine,Division of Toxicology- Karolinska Institutet
Stockholm, Sweden - November, 6 2007 (2-3 PM)
Molecular targeted therapie of cronic myelogeneus leukemia
Tim Bruemmendorf
Klinik für Onkologie/Hämatologie
Hamburg - October, 16 2007 (2-3 PM)
"New approaches for virtual screening"
Giulio Rastelli
Dipartimento di Scienze Farmaceutiche Facolta' di Bioscienze e Biotecnologie Universita' di Modena e Reggio Emilia - October, 9 2007 (2-3 PM)
Computational tools to predict chemical properties, with emphasis on toxicity and endocrine disruption".
Emilio Benfenati
Laboratory of Environmental Chemistry and Toxicology, istituto di Ricerche Farmacologiche "Mario Negri"
via La Masa 19, Milano
Email: benfenati@marionegri.it - October, 2 2007 (2-3 PM)
Post-translational modifications in disease pathogenesis: examples from proteomic studies on a neurodegenerative disorder
Valentina Bonetto
Istituto di Ricerche Farmacologiche "Mario Negri", Milano,Italy
Email: bonetto@marionegri.it - September, 25 2007 (2-3 PM)
Inflammation and cancer: from biology to target validation
Alberto Mantovani
Istituto Clinico Humanitas
Milan, italy - September, 11 2007 (2-3 PM)
Prognostic and therapeutic implications of cancer stem cells from solid tumors
Ruggero De Maria
Istituto Superiore di Sanità-Roma - September, 4 2007 (2,30-3,30 PM)
Integrins, mediators and therapeutic targets of tumor angiogenesis and metastasis
Curzio Ruegg
CePO and ISREC
Epalinges, Switserland - July, 17 2007 (2-3 PM)
A quantitative analysis of the cell cycle molecular regulatory network
Andrea Ciliberto
Computational Cell Biology, IFOM
Via Adamello 16 I-20141 Milan, Italy - June, 19 2007 (2-3 PM)
Therapeutic monoclonal antibodies in oncohematology:factors affecting efficacy
Josee Golay
Division of Hematology, Ospedali Riuniti, Bergamo,Italy - June, 19 2007 (2-3 PM)
Josee Golay and Martino Introna
Laboratory of Cellular and Gene Therapy "G. Lanzani" - May, 22 2007 (11-12 AM)
Translational Research Unit, Unit 10 Department of Experimental Oncology and Laboratories
Maria Grazia Daidone
Istituto Nazionale per lo Studio e la Cura dei Tumori
Via Venezian, 1, 20133 Milan, Italy - May, 15 2007 (2- 3 PM)
Gian Cesare Tron
Dipartimento di Scienze Chimiche, Alimentari, Farmaceutiche e Farmacologiche and Drug and Food Biotechnology Center Universita degli Studi del Piemonte Orientale A. Avogadro
Via Bovio 6, 28100 Novara, Italy
Email: tron@pharm.unipmn.it - April, 10 2007 (2:00 PM)
Reazioni stereoselettive promosse da catalizzatori organici e organometallici
Maurizio Benaglia
University of Milano - April, 3 2007 (2 - 3 PM)
Deoxynucleoside kinases as tools in drug discovery and therapy monitoring
Staffan Eriksson
Department of Anatomy, Physiology and Biochemistry The Swedish University of Agricultural Sciences, BMC - March, 27 2007 (2 - 3 PM)
Sensing and responding to DNA damage
Noel Lowndes
Genome Stability Laboratory Department of Biochemistry and National Centre for Biomedical Engineering Science National University of Ireland Galway, Ireland - March, 13 2007 (2 - 3 PM)
Impact of biocatalysis on the quality of pharmaceutical ingredients
Marco Terreni
Pharmaceutical Biocatalysis Laboratories Università degli Studi di Pavia and INNOVATE BIOTECHNOLOGY S.r.l. - March, 6 2007 (2:00 PM)
Pro-apoptotic activity of NBDHEX, a suicide inhibitor of glutathione transferases
Anna Maria Caccuri
University of Rome "Tor Vergata", Rome - February, 27 2007 (2:00 PM)
Angiogenesis and the tumor microenvironment as target fot therapy and cancer prevention
Adriana Albini
IRCCS Multimedica, Milano - February, 13 2007 (2:00 PM)
Enrico Marcantoni
University of Camerino, Camerino, Italy - February, 6 2007 (2:00 PM)
Thomas Carell
Ludwig-Maximilians University, München, Germany - January, 30 2007 (2:00 PM)
Federico Bussolino
IRCC, Institute for Cancer Research and Treatment, Candiolo, Torino, Italy
Archive 2008
- December, 12 2008 (13:30-14:30 PM)
Ulrich Pfeffer
National Cancer Research Institute
Genova, Italy - November, 21 2008 (1:30-2:30 PM)
David Parker
Department of Chemistry
Durham University, UK - November, 14 2008 (1:30-2:30PM)
Prof Mauro Magnani
Istituto di Chimica Biologica "G. Fornaini",Università degli Studi "Carlo Bo"
Urbino - November, 7 2008
The CD38/NAD+/Cyclic ADP-ribose/intracellular calcium signalling pathway: mechanisms and therapeutic outlook
Antonio De Flora
Department of Experimental Medicine Center of Excellence for Biomedical Research of Genova
Genova - October, 24 2008 (1:30-2:30 PM)
From Mad Cow Disease to Sepsis: how NMR can help
Luigi Calzolai
Medway School of Pharmacy, Universities of Kent and Greenwich at Medway
Chatham Maritime,Kent - October, 17 2008 (10:00-11:00 )
T-cell gene manipulation by chimeric TcR for innovative treatment of acute leukemia
Andrea Biondi
Dipartimento di Medicina Clinica e Prevenzione Direttore, Centro Ricerca M. Tettamanti
Monza (Italy) - October, 10 2008 (1:30-2:30 PM)
Boudewijn Lelieveldt
Division of Image Processing,Department of Radiology,Leiden University Medical Center
Leiden, The Netherlands - September, 26 2008 (1:30-2:30PM)
Cancer mutations and targeted therapies
Alberto Bardelli
Laboratory of Molecular Genetics-The Oncogenomics Center, Institute for Cancer Research and Treatment (IRCC)
Candiolo (Torino) - September, 12 2008 (1:30-2:30 PM)
Leucemia acuta mieloide con mutazione della nucleophosmina:aspetti biologici e clinici
Brunangelo Falini
Institute of Hematology University of Perugia
Perugia - September, 5 2008 (1:30-2:30PM)
The petidyl prolyl isomerase Pin1 is a novel pharmacological target in cancer therapy: enhanced responses of acute myeloid leukemia cells to retinoids
Enrico Garattini
Laboratory of Molecular Biology,Istituto di Ricerche Farmacologiche "Mario Negri"
Via La Masa, 19 Milano - July, 18 2008 (1:30-2:30 PM)
Mode and dynamics of protein-DNA interactions at a human replication origin
Arturo Falaschi
Professore di Biologia Molecolare Scuola Normale Superiore
Pisa - July, 4 2008 (1:30- 2:30 PM)
Mutations of NPM in Acute Myeloid Leukemia
Emanuela Colombo
IFOM-IEO
Milano - June, 27 2008 (11:30-12:30 PM)
Therapeutic potential of cancer stem cells from solid tumors
Ruggero De Maria
Isituo Superiore Sanità
Roma - June, 20 2008 (1:30-2:30 PM)
Polyamines: old molecules, new syntheses, new opportunities. The multicomponent reactions protagonist in the medicinal chemistry
Gian Cesare Tron
Dipartimento di Scienze Chimiche, Alimentari, Farmaceutiche e Farmacologiche and Drug and Food Biotechnology Center
Università Studi del Piemonte Orientale A. Avogadro-Novara - May, 30 2008 (1:30-2:30 PM)
CDC25 phosphatases. Cell cycle regulators and therapeutic targets
Bernard Ducommun
Institut d'Exploration Fonctionnelle des Génomes
Toulouse - May, 23 2008 (1:30- 2:30 PM)
Targeting breast cancer: from the benchside to the bed and vice versa
Giancarlo Pruneri
Division of Pathology and Laboratory Medicine European Institute of Oncology
Milano - May, 16 2008 (1:30-2:30 PM )
The role of the human mismatch repair system in drug resistance
Josef Jiricny
Institute of Molecular Cancer Research,University of Zürich
Zürich - May, 9 2008 (1:30-2:30 PM)
Vascuar tumor targeting: from the bench to the clinic
Dario Neri
Institute of Pharmaceutical Sciences
Swiss Federal Institute of Technology, Zurich - April, 2 2008 (2:30-3:30 PM)
The ubiquitin-dependent chaperone VCP/p97/Cdc48 regulates Aurora-B activity on mitotic chromatin
Hemmo Meyer
ETH Swiss Federal Institute of Technology
Zurich - February, 1 2008 (1:30- 2:30 PM)
Cancer mortality trends in the European Union: priorities for cancer control
Carlo La Vecchia
Head, Laboratory of General Epidemiology,Istituto di Ricerche Farmacologiche "Mario Negri"
Milano
Archive 2009
- November, 27 2009 (1:30 PM)
Targeting human RNA helicases in viral and cancer diseases
Giovanni Maga
Institute of Molecular Genetics IGM-CNR, Pavia, Italy - November, 6 2009 (1:30-2:30 PM)
Stefan Knapp
Professor of Structural ChemistryStructural Genomics Consortium,University of Oxford
Oxford, UK - October, 23 2009 (1:30-2:30 PM)
Turning proteotoxic stress against cancer: the proteasome lessons
Dr Simone Cenci
Division of Genetics and Cell Biology,San Raffaele Scientific Institute
via Olgettina,Milano - September, 25 2009 (1:30-2:30 PM)
De Novo enzyme design for Green chemistry applications
Artur Gora
Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences
Krakow, Poland - September, 11 2009 (1:30-2:30 PM)
Overload in the protein factory. Turning ER stress against cancer
Roberto Sitia
Professor of Molecular Biology Università,Director Division of Genetics and Cell Biology, San Raffaele Scientific Institute
Via Olgettina 58, 20132 Milano - July, 24 2009 (1:30-2:30 PM)
Feedback control of mitosis
Andrea Musacchio
Dept. of Experimental Oncology,European Institute of Oncology
Via Adamello 16, Milano - July, 10 2009 (1:30-2:30 PM)
Sergio Marchini
Dipartimento Oncologia, Laboratorio Chemioterapia Antitumorale
Istituto Mario Negri, Milano - June, 12 2009 (1:30-2:30 PM)
Extended replicative-potential and increased frequency of symmetric self-renewing divisions in cancer stem cells due to attenuated p53-signaling
Giuseppina Bonizzi
Department of Experimental Oncology
European Institute of Oncology, Milano - May, 22 2009 (1:30-2:30 PM)
NAD metabolism in health and disease: a structural biology perspective
Menico Rizzi
DISCAFF (Dipartimento di Scienze Chimiche, Alimentari, Farmaceutiche e Farmacologiche) Università del Piemonte Orientale "Amedeo Avogadro"
Via Giovanni Bovio 6, 28100 Novara, Italy - May, 6 2009 (2:00-3:00 PM)
The role of Hsp90 and the Rvb1-Rvb2-Tah-Pih1 complex in ribosomal RNA processing
Walid Houry
1 King's College Circle Medical Sciences Building,Department of Biochemistry,University of Toronto
Toronto, Ontario - February, 20 2009 (1:30-2:30 PM)
Therapeutic Advances in Colorectal Cancer: Identification of Predictive Biomarkers of Clinical Benefit
Salvatore Siena
Director of The Falck Division of Medical Oncology Ospedale Niguarda Ca' Granda
Piazza Ospedale Maggiore 3, Milano - February, 13 2009 (1:30-2:30 PM)
Leucemia acuta mieloide con mutazione della nucleophosmina: aspetti biologici e clinici
Brunangelo Falini
Institute of Hematology
University of Perugia, Perugia - January, 30 2009 (1:30-2:30 PM)
NAD(P): much more than basic metabolism. From signal transduction to cancer therapy
Armando Genazzani
Dip. di Scienze chimiche, Alimentari, Farmaceutiche e Farmacologiche
Università degli Studi del Piemonte Orientale, Novara - January, 16 2009 (1:30-2:30 PM)
Nuove terapie per le malattie mieloproliferative croniche
Alessandro Rambaldi
Direttore del reparto di Ematologia-Ospedali riuniti di Bergamo
Bergamo
© Nerviano Medical Sciences
VAT No. 04379750963